Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2026)

Vir Biotechnology has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$254000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$254000.0, down 252.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$591000.0 (up 70.54% YoY), and the FY2025 annual result was -$409000.0, up 81.58% from the prior year.
• Other Non Operating Income came in at -$254000.0 for Q1 2026 at Vir Biotechnology, up from -$335000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $27.0 million in Q3 2022 to a low of -$26.2 million in Q4 2022.
• The 5-year median for Other Non Operating Income is -$287000.0 (2024), against an average of -$447941.2.
• Peak annual rise in Other Non Operating Income reached 42128.12% in 2022, while the deepest fall reached 374000.0% in 2022.
• Vir Biotechnology's Other Non Operating Income stood at -$26.2 million in 2022, then jumped by 94.33% to -$1.5 million in 2023, then jumped by 65.93% to -$506000.0 in 2024, then surged by 33.79% to -$335000.0 in 2025, then rose by 24.18% to -$254000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$254000.0 (Q1 2026), -$335000.0 (Q4 2025), and -$228000.0 (Q3 2025), per Business Quant data.